Showing results (2321-2330 of 2,512) with videos related to

Sort By:
Pageof 252
Science Translational Medicine|June 10, 2021
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depressionPeter Nagele, Ben J Palanca, Britt Gott, et al.
Cancer Research|April 23, 2011
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesisAlfred S L Cheng, Suki S Lau, Yangchao Chen, et al.
BMC Systems Biology|July 21, 2009
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modulesHuaxia Qin, Michael W Y Chan, Sandya Liyanarachchi, et al.
Ambio|January 17, 2021
NABat: A top-down, bottom-up solution to collaborative continental-scale monitoringBrian E Reichert, Mylea Bayless, Tina L Cheng, et al.
Cancers|September 9, 2022
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a TrialJohn Hilton, Mihaela Cristea, Sophie Postel-Vinay, et al.
Blood|October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AMLBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Oncogene|December 14, 2017
SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesisTingting Huang, Yuhang Zhou, Jinglin Zhang, et al.
Oncogene|August 8, 2018
FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5pJinglin Zhang, Yuhang Zhou, Tingting Huang, et al.
Gastroenterology|October 13, 2012
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesisAlfred S L Cheng, May S Li, Wei Kang, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 4, 2025
IL-4-mediated Pro-Regenerative Cellular Reprogramming in 3D Liver CultureDamra Camat, Diana Nakib, Sai W Chung, et al.
Pageof 252